InvestorsHub Logo

$heff

09/08/14 12:56 AM

#82967 RE: $heff #82882

$SYN.. Synthetic Biologics highlights new data from C. difficile program.
Synthetic Biologics announced preclinical data that further validate the company's novel approach to preventing Clostridium difficile,C. difficile. The U.S. Centers for Disease Control has identified C. difficile as an "urgent public health threat," and it has surpassed MRSA as the number one hospital-acquired infection in the United States. The data were highlighted on September 6 at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC, in Washington, D.C.

http://finance.yahoo.com/news/synthetic-biologics-highlights-data-c-125800209.html